IGM Biosciences IGMS - Options Chain | InvestorsHub

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NASDAQ
IGM Biosciences Inc (IGMS)
IGM Biosciences Inc (IGMS) Options

IGM Biosciences Inc (IGMS)

10.9988

0.6888

( 6.68% )

Updated: 10:40:35

Delayed by 15 minutes

IGMS Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
12.50	0.40	1.10	0.50	0.75	0.15	42.86 %	5	79	09:58:02
15.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
17.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
20.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Empower your portfolio: Real-time discussions and actionable trading ideas.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
12.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
15.00	3.80	4.90	0.00	4.35	0.00	0.00 %	0	0	-
17.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
20.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DCAPUnity Wealth Partners Dynamic Capital Appreciation & Options ETF	20.10 (839.25%)	128.72k
SLRXSalarius Pharmaceuticals Inc	$ 5.08 (229.87%)	16.08M
ADILAdial Pharmaceuticals Inc	$ 2.25 (112.26%)	121.07M
ATPCAgape ATP Corporation	$ 0.25302 (76.94%)	80.14M
RGCRegencell Bioscience Holdings Ltd	$ 5.42 (60.83%)	16.7k
JAGXJaguar Health Inc	$ 1.5588 (-63.49%)	8.31M
RNAZTransCode Therapeutics Inc	$ 0.30 (-62.15%)	4.36M
MIRAMIRA Pharmaceuticals Inc	$ 3.00 (-40.12%)	15.88M
FLYEFly E Group Inc	$ 3.99 (-37.46%)	2.85M
SLNASelina Hospitality PLC	$ 0.0253 (-31.62%)	53.2M
ADILAdial Pharmaceuticals Inc	$ 2.25 (112.26%)	121.07M
ATPCAgape ATP Corporation	$ 0.25302 (76.94%)	80.14M
WRNTWarrantee Inc	$ 0.2837 (-2.51%)	62.54M
SLNASelina Hospitality PLC	$ 0.0253 (-31.62%)	53.2M
NVDANVIDIA Corporation	$ 123.44 (-0.08%)	51.15M

Monksdream

Monksdream 3 weeks ago

Monksdream

Monksdream 3 months ago

crudeoil24

crudeoil24 2 years ago

Truist Reiterates Buy Rating, $80 Price Target.

crudeoil24

crudeoil24 2 years ago

Let's see if IGMS gets FDA phase I,II,III, approvals . Sanofi believes it'll happen.

crudeoil24

crudeoil24 2 years ago

crudeoil24

crudeoil24 2 years ago

Tons of cash going forward > IGM Biosciences, Inc. (NASDAQ: IGMS) today announced that it intends to offer and sell $200.0 million of shares of its common stock and, in lieu of common stock to certain investors that so choose, non-voting common stock, in an underwritten public offering. In addition, IGM intends to grant the underwriters a 30-day option to purchase up to an additional $30.0 million of shares at the public offering price, less underwriting discounts and commissions. All of the securities offered in the offering will be sold by IGM. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
J.P. Morgan, BofA Securities, Stifel, and Guggenheim Securities are acting as joint book-running managers for the offering.

TheFinalCD

TheFinalCD 2 years ago

https://ih.advfn.com/stock-market/NASDAQ/igm-biosciences-IGMS/stock-news/87682546/igm-announces-proposed-public-offering

https://www.wsgr.com/print/v2/content/185066/Firm-Advises-IGM-Biosciences%2C-Inc.-on-%24230-Million-Public-Offering.pdf

IGM Biosciences

Delayed Upgrade Clock